Clinical Trials Directory

Trials / Conditions / Progressive Familial Intrahepatic Cholestasis (PFIC)

Progressive Familial Intrahepatic Cholestasis (PFIC)

7 registered clinical trials studyying Progressive Familial Intrahepatic Cholestasis (PFIC) — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Famili
NCT07293897
Takeda—
RecruitingFamilial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cance
NCT06777914
IRCCS Azienda Ospedaliero-Universitaria di Bologna—
CompletedA Study of TAK-625 for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC)
NCT05543187
TakedaPhase 3
CompletedAn Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)
NCT04185363
Mirum Pharmaceuticals, Inc.Phase 3
CompletedA Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic
NCT03905330
Mirum Pharmaceuticals, Inc.Phase 3
WithdrawnA Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepati
NCT03353454
Mirum Pharmaceuticals, Inc.Phase 3
CompletedOpen Label Study to Evaluate Efficacy and Long Term Safety of LUM001 (Maralixibat) in the Treatment of Cholest
NCT02057718
Mirum Pharmaceuticals, Inc.Phase 2